TREATMENT PATTERNS AND OUTCOMES IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A COMMUNITY ONCOLOGY SETTING

被引：0
|
作者：
Cartwright, T. H. [1 ]
Pan, I [2 ]
Wen, L. [3 ]
Wadlow, R. C. [4 ]
Rembert, D. [5 ]
Seal, B. [6 ]
机构：
[1] Mckesson Specialty Hlth, Ocala, FL USA
[2] Mckesson Specialty Hlth, Conroe, TX USA
[3] Bayer HealthCare Pharmaceut Inc, Pine Brook, NJ USA
[4] Mckesson Specialty Hlth, Fairfax, VA USA
[5] Mckesson Specialty Hlth, The Woodlands, TX USA
[6] Bayer HealthCare Pharmaceut Inc, White House Stn, NJ USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.407
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN12
引用
收藏
页码：A69 / A70
页数：2
相关论文
共 50 条
  • [1] Treatment patterns and outcomes in metastatic colorectal cancer (mCRC).
    Cartwright, Thomas H.
    Wen, Lonnie Kent
    Harrell, Robyn K.
    Fox, Patricia S.
    Espirito, Janet L.
    Wang, Ed
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [2] TREATMENT PATTERNS AND OUTCOMES IN METASTATIC GASTRIC CANCER IN THE COMMUNITY ONCOLOGY SETTING
    Walker, Mark
    Lalla, Deepa
    Houts, Arthur
    Schwartzberg, Lee
    ANNALS OF ONCOLOGY, 2012, 23 : 47 - 47
  • [3] METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED WITH LATER LINES OF TREATMENT (LOT): A RETROSPECTIVE ANALYSIS BY RACE AND ETHNICITY IN THE UNITED STATES (US) COMMUNITY ONCOLOGY SETTING
    Barzi, A.
    Appukkuttan, S.
    Hocum, B.
    Katta, A.
    Babajanyan, S.
    Cosgrove, D.
    Sruti, I
    Shi, J.
    Dai, W.
    Patton, G.
    Bekaii-Saab, T.
    VALUE IN HEALTH, 2024, 27 (06) : S239 - S239
  • [4] SIGNIFICANT VARIATION IN FIRST-LINE TREATMENT DURATION AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) TREATED IN THE COMMUNITY SETTING
    Klink, A. J.
    Nabhan, C.
    Ernst, F. R.
    Feinberg, B. A.
    VALUE IN HEALTH, 2017, 20 (05) : A138 - A138
  • [5] Treatment patterns and site of metastasis in patients with metastatic colorectal cancer (mCRC)
    Iqbal, Sheikh Usman
    Thompson, Stephen F.
    Naoshy, Sarah
    Ng, Daniel B.
    Wooten, Michael
    Sherman, Steven A.
    Malangone, Elisabetta
    Stern, Lee
    Gorritz-Kindu, Magdaliz
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] CLINICAL OUTCOMES OF BEVACIZUMAB USED IN COMMUNITY ONCOLOGY METASTATIC COLORECTAL CANCER (MCRC) PATIENTS WITH CONFIRMED KRAS-STATUS
    Cartwright, Thomas
    Yim, Yeun Mi
    Yu, Elaine
    Rahul, Dhanda
    Tseng, Wan-Yu
    Forsyth, Michael
    Lopez, William
    ANNALS OF ONCOLOGY, 2012, 23 : 99 - 99
  • [7] Understanding treatment patterns and outcomes in patients with metastatic NSCLC treated in a US community oncology network
    Nadler, Eric S.
    Espirito, Janet L.
    Pavilack, Melissa
    Boyd, Marley
    Vergara-Silva, Andrea Leninka
    Fernandes, Ancilla
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Real-world biomarker testing patterns among patients with metastatic colorectal cancer (mCRC) treated with later lines of therapy (LOT) in the United States (US) community oncology setting.
    Katta, Arvind
    Barzi, Afsaneh
    Hocum, Brian Thomas
    Appukkutan, Sreevalsa
    Cosgrove, David
    Sruti, Ila
    Shi, Junxin
    Dai, Wei
    Patton, Gregory A.
    Babajanyan, Svetlana
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 163 - 163
  • [9] Treatment patterns in metastatic colorectal cancer (mCRC) in Slovakia.
    Salek, Tomas
    Pichna, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Metastatic colorectal cancer (mCRC) treatment patterns in the Medicare population
    Snider, Jeremy
    Wang, Ed
    Anderson, Sibyl
    Steelquist, Jordan
    Warnick, Greg S.
    Fedorenko, Catherine R.
    Shankaran, Veena
    Ramsey, Scott David
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345